Unlocking the potential of tranilast: Targeting fibrotic signaling pathways for therapeutic benefit-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Unlocking the potential of tranilast: Targeting fibrotic signaling pathways for therapeutic benefit

Published:2024-08 Issue: Volume:137 Page:112423
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Massoud Gaelle,Parish Maclaine,Hazimeh Dana,Moukarzel Pamela,Singh Bhuchitra,Cayton Vaught Kamaria C.,Segars James,Islam Md Soriful

Publisher

Elsevier BV

Reference117 articles.

1. Chronic inflammation in the etiology of disease across the life span;Furman;Nat. Med.,2019

2. Mechanisms of fibrosis: therapeutic translation for fibrotic disease;Wynn;Nat. Med.,2012

3. Anti-inflammatory treatments for chronic diseases: a review;Laveti;Inflamm. Allergy Drug Targets,2013

4. Unveiling the power of gabapentin-loaded nanoceria with multiple therapeutic capabilities for the treatment of dry eye disease;Yang;ACS Nano,2023

5. Poly (l-Histidine)-mediated on-demand therapeutic delivery of roughened ceria nanocages for treatment of chemical eye injury;Yang;Adv. Sci.,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological effects and the related mechanism of scutellarin on inflammation-related diseases: a review;Frontiers in Pharmacology;2024-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP